Home » SfNIRS2022 » Clinical Applications » Classification of Impairment from ∆9-tetrahydrocannabinol (THC) using resting-state neuroimaging

Classification of Impairment from ∆9-tetrahydrocannabinol (THC) using resting-state neuroimaging

By in Clinical Applications, SfNIRS2022 on

You must be logged in to view this content.